BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin CY, Yao CA. Potential Role of Nrf2 Activators with Dual Antiviral and Anti-Inflammatory Properties in the Management of Viral Pneumonia. Infect Drug Resist. 2020;13:1735-1741. [PMID: 32606823 DOI: 10.2147/idr.s256773] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhai Z, Huang Y, Zhang Y, Zhao L, Li W. Clinical Research Progress of Small Molecule Compounds Targeting Nrf2 for Treating Inflammation-Related Diseases. Antioxidants (Basel) 2022;11:1564. [PMID: 36009283 DOI: 10.3390/antiox11081564] [Reference Citation Analysis]
2 Fu Y, Ho W, Kang N, Tsai M, Wu J, Huang L, Weng C. Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth. Front Pharmacol 2022;13:863082. [DOI: 10.3389/fphar.2022.863082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hei G, Smith RC, Li R, Ou J, Song X, Zheng Y, He Y, Arriaza J, Fahey JW, Cornblatt B, Kang D, Yang Y, Huang J, Wang X, Cadenhead K, Zhang M, Davis JM, Zhao J, Jin H, Wu R. Sulforaphane Effects on Cognition and Symptoms in First and Early Episode Schizophrenia: A Randomized Double-Blind Trial. Schizophrenia Bulletin Open 2022;3:sgac024. [DOI: 10.1093/schizbullopen/sgac024] [Reference Citation Analysis]
4 Wang Y, Xu C, Yao S, Wang L, Zhao Y, Ren J, Li Y. Estimating the COVID-19 prevalence and mortality using a novel data-driven hybrid model based on ensemble empirical mode decomposition. Sci Rep 2021;11:21413. [PMID: 34725416 DOI: 10.1038/s41598-021-00948-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Emanuele S, Celesia A, D'Anneo A, Lauricella M, Carlisi D, De Blasio A, Giuliano M. The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19. Int J Mol Sci 2021;22:7963. [PMID: 34360732 DOI: 10.3390/ijms22157963] [Reference Citation Analysis]
6 Zhu DD, Tan XM, Lu LQ, Yu SJ, Jian RL, Liang XF, Liao YX, Fan W, Barbier-Torres L, Yang A, Yang HP, Liu T. Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury. World J Gastroenterol 2021; 27(22): 2944-2962 [PMID: 34168400 DOI: 10.3748/wjg.v27.i22.2944] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
7 Mahn A, Castillo A. Potential of Sulforaphane as a Natural Immune System Enhancer: A Review. Molecules 2021;26:752. [PMID: 33535560 DOI: 10.3390/molecules26030752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
8 Rahban M, Habibi-Rezaei M, Mazaheri M, Saso L, Moosavi-Movahedi AA. Anti-Viral Potential and Modulation of Nrf2 by Curcumin: Pharmacological Implications. Antioxidants (Basel) 2020;9:E1228. [PMID: 33291560 DOI: 10.3390/antiox9121228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bousquet J, Cristol JP, Czarlewski W, Anto JM, Martineau A, Haahtela T, Fonseca SC, Iaccarino G, Blain H, Fiocchi A, Canonica GW, Fonseca JA, Vidal A, Choi HJ, Kim HJ, Le Moing V, Reynes J, Sheikh A, Akdis CA, Zuberbier T; ARIA group. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies. Clin Transl Allergy 2020;10:58. [PMID: 33292691 DOI: 10.1186/s13601-020-00362-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
10 Wang Y, Xu C, Yao S, Zhao Y. Forecasting the epidemiological trends of COVID-19 prevalence and mortality using the advanced α-Sutte Indicator. Epidemiol Infect 2020;148:e236. [PMID: 33012300 DOI: 10.1017/S095026882000237X] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]